There's gotta be a clear O.S. benefit they saw as well. Merck's recent comments pretty much clarify they have everything to meet primary and secondary endpoints.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.